140 related articles for article (PubMed ID: 31914438)
1. Intravoxel Incoherent Motion of Colon Cancer Liver Metastases for the Assessment of Response to Antiangiogenic Treatment: Results from a Pilot Study.
Öz A; Server S; Koyuncu Sökmen B; Namal E; İnan N; Balcı NC
Med Princ Pract; 2020; 29(5):429-435. PubMed ID: 31914438
[TBL] [Abstract][Full Text] [Related]
2. Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
Granata V; Fusco R; Catalano O; Filice S; Amato DM; Nasti G; Avallone A; Izzo F; Petrillo A
PLoS One; 2015; 10(11):e0142876. PubMed ID: 26566221
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single Center Analysis.
Pieper CC; Sprinkart AM; Meyer C; König R; Schild HH; Kukuk GM; Mürtz P
Medicine (Baltimore); 2016 Apr; 95(14):e3275. PubMed ID: 27057887
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
Kim JH; Joo I; Kim TY; Han SW; Kim YJ; Lee JM; Han JK
AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
[TBL] [Abstract][Full Text] [Related]
5. DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases.
Rata M; Khan K; Collins DJ; Koh DM; Tunariu N; Bali MA; d'Arcy J; Winfield JM; Picchia S; Valeri N; Chau I; Cunningham D; Fassan M; Leach MO; Orton MR
Cancer Imaging; 2021 Dec; 21(1):67. PubMed ID: 34924031
[TBL] [Abstract][Full Text] [Related]
6. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
[TBL] [Abstract][Full Text] [Related]
7. Intravoxel incoherent motion diffusion-weighted imaging for early assessment of combined anti-angiogenic/chemotherapy for colorectal cancer liver metastases.
Wu H; Li B; Yang Z; Ji H; Guo Y; Lin J; Wang X
Quant Imaging Med Surg; 2022 Sep; 12(9):4587-4600. PubMed ID: 36060592
[TBL] [Abstract][Full Text] [Related]
8. The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
Kovač JD; Daković M; Janković A; Mitrović M; Dugalić V; Galun D; Đurić-Stefanović A; Mašulović D
PLoS One; 2021; 16(2):e0247301. PubMed ID: 33606753
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion-weighted imaging in an orthotopic hepatocellular carcinoma xenograft model.
Yang SH; Lin J; Lu F; Han ZH; Fu CX; Lv P; Liu H; Gao DM
J Magn Reson Imaging; 2017 Jan; 45(1):270-280. PubMed ID: 27299302
[TBL] [Abstract][Full Text] [Related]
10. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases.
Andreou A; Koh DM; Collins DJ; Blackledge M; Wallace T; Leach MO; Orton MR
Eur Radiol; 2013 Feb; 23(2):428-34. PubMed ID: 23052642
[TBL] [Abstract][Full Text] [Related]
11. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
Hou J; Yu X; Hu Y; Li F; Xiang W; Wang L; Wang H; Lu Q; Zhang Z; Zeng W
Medicine (Baltimore); 2016 Aug; 95(35):e4320. PubMed ID: 27583847
[TBL] [Abstract][Full Text] [Related]
12. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
[TBL] [Abstract][Full Text] [Related]
13. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
Matsushima S; Sato T; Nishiofuku H; Sato Y; Murata S; Kinosada Y; Era S; Inaba Y
Clin Imaging; 2017; 41():1-6. PubMed ID: 27721090
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.
Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
Eur J Radiol; 2019 Oct; 119():108635. PubMed ID: 31445487
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravoxel incoherent motion imaging, diffusion kurtosis imaging, and conventional DWI in predicting the chemotherapeutic response of colorectal liver metastases.
Zhang H; Li W; Fu C; Grimm R; Chen Z; Zhang W; Qiu L; Wang C; Zhang X; Yue L; Hu X; Guo W; Tong T
Eur J Radiol; 2020 Sep; 130():109149. PubMed ID: 32659615
[TBL] [Abstract][Full Text] [Related]
16. Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis?
Chiaradia M; Baranes L; Van Nhieu JT; Vignaud A; Laurent A; Decaens T; Charles-Nelson A; Brugières P; Katsahian S; Djabbari M; Deux JF; Sobhani I; Karoui M; Rahmouni A; Luciani A
J Magn Reson Imaging; 2014 Feb; 39(2):317-25. PubMed ID: 23723012
[TBL] [Abstract][Full Text] [Related]
17. Differentiating atypical hemangiomas and vertebral metastases: a field-of-view (FOV) and FOCUS intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) study.
Cao J; Gao S; Zhang C; Zhang Y; Sun W; Cui L
Eur Spine J; 2020 Dec; 29(12):3187-3193. PubMed ID: 33078268
[TBL] [Abstract][Full Text] [Related]
18. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?
Hectors SJ; Wagner M; Besa C; Bane O; Dyvorne HA; Fiel MI; Zhu H; Donovan M; Taouli B
J Magn Reson Imaging; 2016 Oct; 44(4):856-64. PubMed ID: 26919327
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.
Kakite S; Dyvorne H; Besa C; Cooper N; Facciuto M; Donnerhack C; Taouli B
J Magn Reson Imaging; 2015 Jan; 41(1):149-56. PubMed ID: 24415565
[TBL] [Abstract][Full Text] [Related]
20. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
